**Question:** The pseudomyxoma peritonei occurs as a complication of the following ovarian tumor:

A. Serous cystadenoma
B. Mucinous cystadenoma
C. Serous borderline tumor
D. Mucinous borderline tumor

**Core Concept:** Pseudomyxoma peritonei is a clinical condition characterized by the accumulation of mucinous fluid in the peritoneal cavity, often resulting from the rupture of a mucin-producing ovarian tumor.

**Why the Correct Answer is Right:** The correct answer is mucinous cystadenoma (option B) because it is a benign tumor that produces mucin, a gel-like substance made up of carbohydrates and water. When this tumor ruptures, the mucinous content spreads into the peritoneal cavity, causing pseudomyxoma peritonei. In contrast, serous cystadenoma (A) does not produce mucin and so does not cause pseudomyxoma peritonei. Similarly, serous borderline tumor (C) and mucinous borderline tumor (D) are also types of mucin-producing tumors but are considered malignant or borderline malignant, and thus, will typically result in more severe and widespread complications.

**Why Each Wrong Option is Incorrect:**

A. Serous cystadenoma (A) is a benign tumor that produces very little to no mucin, making it a less likely cause of pseudomyxoma peritonei.
B. Serous cystadenoma (A) and serous borderline tumor (C) are not the correct answers as they do not produce mucin and are not associated with pseudomyxoma peritonei.
C. Serous borderline tumor (C) is a malignant tumor that produces mucin but is considered less malignant than mucinous carcinoma. It is less likely to cause pseudomyxoma peritonei compared to mucinous cystadenoma (B) due to its lower mucin production.
D. Mucinous borderline tumor (D) is considered a malignant tumor producing mucin, but it is more malignant than serous borderline tumor (C) and less malignant than mucinous carcinoma. It is also less likely to cause pseudomyxoma peritonei compared to mucinous cystadenoma (B) due to its higher mucin production.

**Clinical Pearl:** Pseudomyxoma peritonei is a clinical entity associated with mucin-producing ovarian tumors, particularly mucinous cystadenomas and borderline tumors. Understanding the production and malignant potential of these tumors is essential for differentiating between benign, borderline, and malignant conditions that could lead to pseudomyxoma peritonei. This knowledge is critical for appropriate management strategies and patient care.